Literature DB >> 18434110

Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans.

Kazutaka Higaki1, Sally Y Choe, Raimar Löbenberg, Lynda S Welage, Gordon L Amidon.   

Abstract

The relationship of gastric motor activity and gastric emptying of 0.7 mm caffeine pellets with their absorption was investigated in the fed state in healthy human subjects by simultaneous monitoring of antral motility and plasma concentrations. A kinetic model for gastric emptying-dependent absorption yielded multiple phases of gastric emptying and rate constants (k(g)) with large inter-individual differences and large variability in onset of gastric emptying (50-175 min). The model suggests that 50% of the dose is emptied in 1-2h and over 90% emptied by 3.5h following dosing, in all subjects. The maximum values of k(g) (k(g)(max)) were much greater than those reported for emptying of liquids in the fasted state and were comparable to k(g) values in the late Phase II/III of the migrating motor complex (MMC). The model described the observed irregular absorption rate-time and plasma concentration-time profiles adequately but not in detail. The model was more successful at simulating double-peak phenomena in absorption rate profiles and onset of caffeine absorption. The results suggest that gastric emptying regulates drug absorption of small particles in the fed state. Further, estimates of k(a) derived using the time-dependent absorption model were closer to the intrinsic absorption rate constant for caffeine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434110     DOI: 10.1016/j.ejpb.2008.02.022

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  C (max) and t (max) verification using Fibonacci sequence and absorption rate.

Authors:  Tomasz Grabowski; Jerzy J Jaroszewski; Beata Borucka; Hubert Ziółkowski
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-07-14       Impact factor: 2.441

4.  Differences in lercanidipine systemic exposure when administered according to labelling: in fasting state and 15 minutes before food intake.

Authors:  Covadonga Álvarez; Estrella Gómez; Marta Simón; Carlos Govantes; Pedro Guerra; Jesús Frías; Alfredo García-Arieta
Journal:  Eur J Clin Pharmacol       Date:  2012-02-01       Impact factor: 2.953

Review 5.  Physiological parameters for oral delivery and in vitro testing.

Authors:  Deanna M Mudie; Gordon L Amidon; Gregory E Amidon
Journal:  Mol Pharm       Date:  2010-09-07       Impact factor: 4.939

6.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

7.  New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.

Authors:  J B Bulitta; C B Landersdorfer; M Kinzig; U Holzgrabe; F Sorgel
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

Review 8.  Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.

Authors:  Timothy R Lex; Jason D Rodriguez; Lei Zhang; Wenlei Jiang; Zongming Gao
Journal:  AAPS J       Date:  2022-03-11       Impact factor: 4.009

Review 9.  Caffeine in the management of patients with headache.

Authors:  Richard B Lipton; Hans-Christoph Diener; Matthew S Robbins; Sandy Yacoub Garas; Ketu Patel
Journal:  J Headache Pain       Date:  2017-10-24       Impact factor: 7.277

10.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.

Authors:  Marival Bermejo; Paulo Paixão; Bart Hens; Yasuhiro Tsume; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Löbenberg; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Niloufar Salehi; Arjang Talattof; Gail Benninghoff; Duxin Sun; Gislaine Kuminek; Katie L Cavanagh; Naír Rodríguez-Hornedo; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.